Working… Menu

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01799538
Recruitment Status : Recruiting
First Posted : February 26, 2013
Last Update Posted : January 15, 2021
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )